Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Pat
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacer
| Condition(s) | Pulmonary Disease, Chronic Obstructive |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, effor |
| Who can participate | Inclusion Criteria: * Being diagnosed with stage 4 (group D) COPD according to GOLD criteria * Being 18 years or older, * Having a video computer, tablet or phone, * Having an internet connection at home or on the phone, * Residing in the city centre of Konya, * Not having a communication problem, such as an inability to understand/speak Turkish, that would prevent participation in the research, * Being literate, * Using an oxygen concentrator at home. Exclusion Criteria: * Being illiterate, * Being diagnosed with first, second and third-stage COPD according to GOLD criteria, * Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.), * Having physical and/or mental disabilities, * Being visually impaired and/or hearing impaired, * Having a communication problem that prev |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Necmettin Erbakan University |
| Locations | Konya, Turkey (Türkiye) |
| Start date | 2023-02-15 |
| NCT ID | NCT05730088 |
| Official listing | https://clinicaltrials.gov/study/NCT05730088 |